These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15923586)

  • 1. Inflammatory breast cancer and high-dose chemotherapy: back to the past.
    Gonzalez-Angulo AM; Morandi P; Cristofanilli M
    J Clin Oncol; 2005 Jun; 23(16):3859-60; author reply 3860-2. PubMed ID: 15923586
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.
    Vogl DT; Stadtmauer EA
    Bone Marrow Transplant; 2006 Jun; 37(11):985-7. PubMed ID: 16708060
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards the integration of hematopoietic stem cells into therapy of breast cancer?
    Siena S
    Haematologica; 1999 Oct; 84(10):865-7. PubMed ID: 10509030
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer].
    Viens P; Maraninchi D
    Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer.
    Pugliese P; Danova M; Brugnatelli S; Piccolo G; Riccardi A; Ascari E
    Haematologica; 2000 Jun; 85(6):672. PubMed ID: 10870133
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose chemotherapy for breast cancer.
    Gratwohl A; Baldomero H; Rosti G
    Bone Marrow Transplant; 2000 Sep; 26(6):599. PubMed ID: 11041563
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical results in 2001 show high dose therapy and hematopoietic progenitor cell transplantation as a therapeutic option for breast cancer.
    Pedrazzoli P; Siena S
    Haematologica; 2001 Sep; 86(9):900-7. PubMed ID: 11532617
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose chemotherapy for malignancies: a review.
    Roman-Unfer S; Bitran JD
    Compr Ther; 1996 Feb; 22(2):107-20. PubMed ID: 8689864
    [No Abstract]   [Full Text] [Related]  

  • 10. Current legal intervention regarding "experimental" treatments must be changed: an analysis of high doses of chemotherapy with autologous bone marrow transplantation for breast cancer patients.
    Smayda E
    J Law Health; 1998-1999; 13(2):257-80. PubMed ID: 10947396
    [No Abstract]   [Full Text] [Related]  

  • 11. Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
    Cheng YC; Ueno NT
    Womens Health (Lond); 2010 Jul; 6(4):481-5. PubMed ID: 20597609
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
    Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
    Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
    Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
    Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
    Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ
    Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced and inflammatory breast cancer.
    Ahern V; Brennan M; Ung O; Kefford R
    Aust Fam Physician; 2005 Dec; 34(12):1027-32. PubMed ID: 16333485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer: Needs in care and therapy].
    Kaulen H
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():72-3. PubMed ID: 16379248
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast cancer (non-metastatic).
    Dixon JM; Rodger A; Stebbing J
    Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
    Nieboer P; de Vries EG; Mulder NH; Rodenhuis S; Bontenbal M; van der Wall E; van Hoesel QG; Smit WM; Hupperets P; Voest EE; Nooij MA; Boezen HM; van der Graaf WT
    Bone Marrow Transplant; 2008 Oct; 42(7):475-81. PubMed ID: 18622420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
    Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S
    Breast J; 2006; 12(6):531-5. PubMed ID: 17238982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.